Orthofix’s Blackstone Medical hires new president to save flagging performance
This article was originally published in Clinica
Brad Mason has been named as the president of Blackstone Medical (Springfield, Massachusetts), the spine implant and biologic subsidiary of Orthofix International. His appointment will not affect his current role as Orthofix’s group president for North America, which will continue. Mr Mason will step into the role formerly held by Oliver Burckhardt, who is leaving the company to pursue other opportunities. Alan Milinazzo, Orthofix CEO said that Blackstone had not performed well during the first half of 2008 and that Mr Mason’s “proven leadership skills” and “extensive product development and distribution experience” were expected to strengthen its capabilities and lift performance.